Literature DB >> 9152717

Behaviour disturbance and other predictors of carer burden in Alzheimer's disease.

R F Coen1, G R Swanwick, C A O'Boyle, D Coakley.   

Abstract

OBJECTIVE: To investigate predictors of carer burden in Alzheimer's disease (AD).
DESIGN: Two cohorts were formed, one comprising AD patients, the other comprising their primary carers. The relationship of patient and carer variables to carer burden was investigated.
SETTING: An urban hospital memory clinic. PARTICIPANTS: A convenience sample of 50 patients meeting NINCDS-ADRDA for probable AD, age range 60-87, and their primary carers, age range 31-84. MEASURES: The Cambridge Cognitive Examination (CAMCOG), the Mini-Mental State Examination (MMSE), the Baumgarten et al. Dementia Behaviour Disturbance Scale, the Blessed-Roth Dementia Scale, the Personal Self-Maintenance Scale, the Zarit Burden Interview and the Vaux et al. Social Support Appraisals (SS-A) and Social Support Behaviours (SS-B) Scales.
RESULTS: Daughters were particularly prone to burden. Neither patient cognitive nor functional status predicted burden. Behaviour disturbance in particular, and informal support were significant, but independent, predictors of carer burden.
CONCLUSIONS: In this study increased carer burden was related independently to increased levels of patient behaviour disturbance and decreased levels of informal social support. This may have relevance to appropriate interventions for carers. As the study was based on a convenience sample of memory clinic attenders, replication in less highly selected samples is desirable.

Entities:  

Mesh:

Year:  1997        PMID: 9152717

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  44 in total

Review 1.  Quality of life: impact of chronic illness on the partner.

Authors:  J Rees; C O'Boyle; R MacDonagh
Journal:  J R Soc Med       Date:  2001-11       Impact factor: 5.344

2.  Effect of second-generation antipsychotics on caregiver burden in Alzheimer's disease.

Authors:  Somaia Mohamed; Robert Rosenheck; Constantine G Lyketsos; Richard Kaczynski; David L Sultzer; Lon S Schneider
Journal:  J Clin Psychiatry       Date:  2011-09-06       Impact factor: 4.384

3.  A pilot study of immune and mood outcomes of a community-based intervention for dementia caregivers: the PLST intervention.

Authors:  Linda Garand; Kathleen C Buckwalter; David Lubaroff; Toni Tripp-Reimer; Rita A Frantz; Timothy N Ansley
Journal:  Arch Psychiatr Nurs       Date:  2002-08       Impact factor: 2.218

Review 4.  [Efficacy of caregiver support groups for dementia].

Authors:  A Kurz; J Hallauer; S Jansen; J Diehl
Journal:  Nervenarzt       Date:  2005-03       Impact factor: 1.214

5.  Behavioral disturbance in dementia.

Authors:  Abhilash K Desai; Lori Schwartz; George T Grossberg
Journal:  Curr Psychiatry Rep       Date:  2012-08       Impact factor: 5.285

6.  Unique contribution of family functioning in caregivers of patients with mild to moderate dementia.

Authors:  Geoffrey Tremont; Jennifer Duncan Davis; Duane S Bishop
Journal:  Dement Geriatr Cogn Disord       Date:  2006-01-03       Impact factor: 2.959

7.  Antipsychotics and cognitive decline in Alzheimer's disease: the LASER-Alzheimer's disease longitudinal study.

Authors:  G Livingston; A E Walker; C L E Katona; C Cooper
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-06-26       Impact factor: 10.154

8.  Spouses, adult children, and children-in-law as caregivers of older adults: a meta-analytic comparison.

Authors:  Martin Pinquart; Silvia Sörensen
Journal:  Psychol Aging       Date:  2011-03

9.  Risk of antipsychotic drug use in patients with Alzheimer's disease treated with rivastigmine.

Authors:  Dong-Churl Suh; Stephen Arcona; Simu K Thomas; Christopher Powers; Adrian L Rabinowicz; Hyunchul Shin; Dario Mirski
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

10.  Neuropsychiatric symptoms as a predictor of caregiver burden in Alzheimer's disease.

Authors:  Ricardo F Allegri; Diego Sarasola; Cecilia M Serrano; Fernando E Taragano; Raúl L Arizaga; Judith Butman; Leandro Loñ
Journal:  Neuropsychiatr Dis Treat       Date:  2006-03       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.